|Having trouble viewing this email? View it as a Web page.
You are subscribed to either CDC’s ACIP Home Page or ACIP Meeting Page email subscription service.
The summary of recommendations approved by majority vote of ACIP members at the ACIP meeting of October 19-20 has been updated.
- For hepatitis B vaccine, ACIP recommended the birth dose within 24 hours of birth for medically stable infants weighing >2,000 grams and born to HBsAg-negative mothers, removal of the permissive language to delay the hepatitis B vaccine birth dose, and approved the revised statement.
- For meningococcal vaccines, ACIP provided guidance on the updated dosing schedules for one serogroup B meningococcal vaccine, MenB-FHbp (Trumenba). For persons at risk for meningococcal disease and during serogroup B outbreaks, 3 doses of MenB-FHbp administered at 0, 1-2, and 6 months; when given to healthy adolescents not at increased risk for meningococcal disease, 2 doses of MenB-FHbp at 0 and 6 months.
See ACIP Votes, October 2016.